More meaningfully, the overexpression of LBX2-AS1 is highly associated with the clinical characteristics of patients, such as tumor stage, lymph node metastasis, and overall survival rate, indicating that LBX2-AS1 has great clinical value as a novel cancer biomarker. Here, LBX2 is linked to neoplasm.